Picture EBD Group World of Partnering Opportunities 650x100px
All >

News > Austria

Total search results: 173 | Ordered by Date (descending)
1 2  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
IMBA – Institute of Molecular Biotechnology GmbH. (3/14/24). "Press Release: Elly Tanaka – IMBA’s New Scientific Director". 2024-03-14
Evomedis GmbH. (11/23/23). "Press Release: Evomedis Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation". Graz. 2023-11-23
OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection". 2023-11-07
Valanx Biotech GmbH. (11/7/23). "Press Release: Valanx Biotech Announces Successful Fundraise of 2.3 M EUR". Klosterneuburg. 2023-11-07 AG. (11/02/23). "Press Release: Raises € 4.5 Million in Pre-Series A Financing to Drive Development of Organoid Screening Platform for Cardiac Drug Discovery". Vienna. 2023-11-02
CMBlu Energy AG. (10/23/23). "Press Release: Technology Group STRABAG Invests 100 Million Euros into Battery and Energy Storage Company CMBlu Energy". Alzenau. 2023-10-23
Biotech Austria. (10/17/23). "Press Release: Inaugural Biotech Summit Austria Sets the Agenda for Emerging Biotech Innovation". Graz. 2023-10-17
Kern Tec. (9/27/23). "Press Release: Kern Tec Raises €12 Million in Series A Funding to Scale Technology that Turns Food Waste into Food Ingredients". Vienna. 2023-09-27
Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna. 2023-09-05
QbD Group. (5/25/23). "Press Release: The QbD Group Acquires Michor Consulting to Enhance Its Regulatory Affairs Services across Europe". 2023-05-25
aws Gründerfonds. (5/24/23). "Pressemitteilung: aws Gründungsfonds II. Neuer Venture Capital Fonds für innovative Technologien sucht die besten Start-ups". 2023-05-24
Evomedis GmbH. (5/12/23). "Press Release: European Commission Grants Orphan Drug Designation for EVOCellic". 2023-05-12
LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer". 2023-05-02
Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna. 2023-04-05
Proxygen GmbH. (3/15/23). "Press Release: Proxygen Announces Formation of Board of Directors". Vienna. 2023-03-15
aws Gründerfonds. (12/23/22). "Pressemitteilung: aws Gründerfonds investiert in nachhaltiges Lebensmittel-Startup Arkeon". Tulln & Wien. 2022-12-23
Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. 2022-11-17
Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. 2022-10-19 AG. (10/5/22). "Press Release: Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna. 2022-10-05
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". 2022-09-27 AG. (9/12/22). "Press Release: and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA. 2022-09-12
Quantro Therapeutics GmbH. (8/3/22). "Press Release: Quantro Therapeutics Collaborates with Boehringer Ingelheim to Develop Drug Candidates Interfering with Transcriptional Regulators". Vienna. 2022-08-03
Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad. 2022-08-02
Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. 2022-06-02
Apeiron Biologics AG. (4/26/22). "Press Release: Apeiron Shareholders Approve New Group Structure Geared towards Enabling Innovation and Growth". Vienna. 2022-04-26
Celeris Therapeutics GmbH. (4/4/22). "Press Release: Celeris Therapeutics and Boehringer Ingelheim Enter Collaboration to Develop Next-generation Targeted Protein Degraders". Menlo Park, CA. 2022-04-04
European Invesmtent Bank (EIB). (3/24/22). "Press Release: Austria – EIB Supports Innovacell’s Innovative Cell Therapy for Treating Incontinence". 2022-03-24
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. 2022-02-15
Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. 2022-02-10
Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. 2022-02-09
Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". 2022-02-02
Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. 2022-01-31
Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck. 2022-01-24
Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg. 2022-01-21
Sanofi S.A.. (12/1/21). "Press Release: Sanofi to Acquire Origimm Biotechnology in First Move to Treat Acne with Vaccine-based Immunotherapy". Paris & Vienna. 2021-12-01
aws Gründerfonds. (11/23/21). "Press Release: Innerspace Receives Seven-figure Investment". Vienna. 2021-11-23
EIT Health e.V.. (11/9/21). "Press Release: EIT Health-supported PhagoMed Acquired by BioNTech". 2021-11-09
Celeris Therapeutics GmbH. (11/1/21). "Press Release: Celeris Therapeutics, the Pioneer in AI-driven Degrader Design, Builds Laboratories in Austria". Graz. 2021-11-01
Boehringer Ingelheim. (10/6/21). "Press Release: Boehringer Ingelheim Inaugurates Biopharmaceutical Production Facility in Vienna, Austria". Ingelheim. 2021-10-06
Hookipa Pharma Inc.. (10/6/21). "Press Release: Groundbreaking Ceremony for Hookpia’s New Production Site". Vienna. 2021-10-06
Delta 4 GmbH. (9/27/21). "Press Release: Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board". Vienna. 2021-09-27
Celeris Therapeutics GmbH. (8/27/21). "Press Release: Celeris Therapeutics Welcomes Life Sciences and Technology Thought Leader Ian Marks as a Non-Executive Director". Menlo Park, CA. 2021-08-27
AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne. 2021-07-27
High-Tech Gründerfonds Management GmbH. (7/5/21). "Press Release: Cutanos Closes First Financing Round with Investor Consortium from Austria and Germany". Vienna. 2021-07-05
Max Planck Innovation GmbH. (7/5/21). "Press Release: Targeted Immune Stimulation for more Effective Vaccines. Cutanos, a Spin-off from the Max Planck Society, Is Developing Novel Vaccines and Immunotherapies". 2021-07-05
Delta 4 GmbH. (6/25/21). "Press Release: Alfred Steininger to Join Delta4 as CFO". 2021-06-25
Exscientia Ltd.. (6/15/21). "Press Release: Exscientia Acquires Personalised Medicine AI Pioneer Allcyte". 2021-06-15
BASF SE. (5/3/21). "Press Release: BASF Strengthens Its Global Production Footprint for Enzymes. BASF Will Invest at Novartis’ Kundl/Schaftenau Campus, in Austria". 2021-05-03
Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. 2021-04-07
Allcyte GmbH. (3/25/21). "Press Release: Austrian Biotech Allcyte Raises $6m Seed Round Following Breakthrough Cancer Clinical Trial". 2021-03-25
Chemieanlagenbau Chemnitz GmbH. (3/1/21). "Press Release: CAC Builds Biofuel Plant for OMV in Schwechat (A)". Chemnitz. 2021-03-01
Sarcura GmbH. (3/21). "Press Release: Sarcura Received a 1.5 m € Research Grant from FFG". 2021-03-01
Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. 2021-02-22
Novartis AG. (2/11/21). "Press Release: Sandoz Announces Agreement to Acquire GSK’s Cephalosporin Antibiotics Business, Reinforcing Its Leading Global Position in Antibiotics". Basel. 2021-02-11
Sarcura GmbH. (1/31/21). "Press Release: Sarcura and imec to Collaborate on High Throughput Cytometry Solution for Automated (T-)Cell Separation, Tackling Manufacturing Challenges of CGT". Klosterneuburg & Leuven. 2021-01-31
Biotech Austria. (12/10/20). "Press Release: Austria’s Biotechnology Companies Establish Biotech Austria – Biotech Industry Association". Vienna. 2020-12-10
OpGen, Inc.. (12/9/20). "Press Release: OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics". Gaithersburg, MD & Vienna. 2020-12-09
Boehringer Ingelheim. (12/7/20). "Press Release: Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders – a Novel Approach to Fight Cancer". Ingelheim & Vienna. 2020-12-07
Sarcura GmbH. (11/19/20). "Press Release: Sarcura Raises a 2.5 M€ Seed Round. Start-up Advances Their Transformative Manufacturing Platform for Autologous Cell Therapies". Klosterneuburg. 2020-11-19
Apeiron Biologics AG. (11/9/20). "Press Release: Apeiron Biologics AG and Domainex Ltd Announce the Expansion of Their Partnership to Progress Targeted Cancer Immune Therapy Drug Discovery". Vienna & Saffron Waldon. 2020-11-09
Biosynth Carbosynth. (11/3/20). "Press Release: Biosynth Carbosynth Expands Its Enzyme Offerings with Products for Industrial Applications". 2020-11-03
Proxygen GmbH. (7/31/20). "Press Release: Boehringer Ingelheim Awards Proxygen with BI Innovation Prize". Vienna. 2020-07-31
Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. 2020-07-21
DeepSpin GmbH. (6/30/20). "Press Release: Berlin-based DeepSpin Raises Seed Round to Revolutionize Medical Imaging". Berlin. 2020-06-30
Apeiron Biologics AG. (6/3/20). "Press Release: Apeiron Biologics Closes Oversubscribed Financing Round of EUR 17.5 Million for the Development of APN01 against COVID-19". Vienna. 2020-06-03
Delta 4 GmbH. (6/2/20). "Press Release: Delta 4 Announces Results Achieved with Drug Discovery Platform". Vienna. 2020-06-02
Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ. 2020-05-26
Apeiron Biologics AG. (5/18/20). "Press Release: Apeiron Biologics Announces Financing Round for the Further Development of the COVID-19 Drug APN01". Vienna. 2020-05-18
Apeptico Forschung und Entwicklung GmbH. (4/7/20). "Press Release: Solatide Has Been Approved by the Austrian Federal Office for Safety in Health Care for the Treatment of COVID-19 Patients with Severe Pulmonary Dysfunction". Vienna. 2020-04-07
Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. 2020-04-06
Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. 2020-04-06
Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. 2020-04-02
OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. 2020-03-18
Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. 2020-03-04
ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. 2020-02-11
CellTool GmbH. (1/20/20). "Press Release: CellTool Appoints Wulf Fischer-Knuppertz as CEO". Tutzing. 2020-01-20
Innate Pharma S.A.. (12/13/19). "Press Release: Innate Pharma Provides Update on Lacutamab TELLOMAK Trial". Marseille. 2019-12-13
SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. 2019-11-26
Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. 2019-10-29
Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. 2019-10-28
PhagoMed Biopharma GmbH. (10/22/19). "Press Release: Phage Lysin Stabilzes Vaginal Microbiome. PhageMed Accelerates R6D Program against Bacterial Vaginosis". Vienna. 2019-10-22
Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". 2019-09-24
Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. 2019-09-18
Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. 2019-09-16
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. 2019-09-12
Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. 2019-08-22
Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. 2019-08-08
IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". 2019-08-07
Platomics GmbH. (8/6/19). "Press Release: 7-digit Investment in Future Technology Genetic Testing". 2019-08-06
PhagoMed Biopharma GmbH. (6/27/19). "Press Release: Further Investment for PhagoMed. Investors Support Phage Therapy". Vienna. 2019-06-27
Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. 2019-06-04
ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. 2019-04-23
Curetis N.V.. (4/12/19). "Press Release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019". Vienna, Holzgerlingen & Amsterdam. 2019-04-12
Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. 2019-04-04
Curetis N.V.. (4/2/19). "Press Release: Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance". Amsterdam & Holzgerlingen. 2019-04-02
Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna. 2019-02-25
Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. 2019-02-18
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". 2019-01-29
1 2  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top